GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (SHSE:600332) » Definitions » 5-Year Yield-on-Cost %

Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) 5-Year Yield-on-Cost % : 4.49 (As of May. 27, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co 5-Year Yield-on-Cost %?

Guangzhou Baiyunshan Pharmaceutical Holdings Co's yield on cost for the quarter that ended in Mar. 2024 was 4.49.


The historical rank and industry rank for Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:600332' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.5   Med: 2.42   Max: 7.33
Current: 4.49


During the past 13 years, Guangzhou Baiyunshan Pharmaceutical Holdings Co's highest Yield on Cost was 7.33. The lowest was 0.50. And the median was 2.42.


SHSE:600332's 5-Year Yield-on-Cost % is ranked better than
86.85% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.125 vs SHSE:600332: 4.49

Competitive Comparison of Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost % falls into.



Guangzhou Baiyunshan Pharmaceutical Holdings Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Guangzhou Baiyunshan Pharmaceutical Holdings Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Guangzhou Baiyunshan Pharmaceutical Holdings Co  (SHSE:600332) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Guangzhou Baiyunshan Pharmaceutical Holdings Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Business Description

Traded in Other Exchanges
Address
89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.

Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Headlines

No Headlines